TY - JOUR AU - Flier, W. M. AU - Skoog, I. AU - Schneider, J. A. AU - Pantoni, L. AU - Mok, V. AU - Chen, C. L. H. PY - 2018 DA - 2018// TI - Vascular cognitive impairment JO - Nat Rev Dis Primers VL - 4 UR - https://doi.org/10.1038/nrdp.2018.3 DO - 10.1038/nrdp.2018.3 ID - Flier2018 ER - TY - JOUR AU - Bowler, J. V. PY - 2005 DA - 2005// TI - Vascular cognitive impairment JO - J Neurol Neurosurg Psychiatry VL - 76 UR - https://doi.org/10.1136/jnnp.2005.082313 DO - 10.1136/jnnp.2005.082313 ID - Bowler2005 ER - TY - JOUR AU - Bohnen, N. I. AU - Muller, M. L. AU - Kuwabara, H. AU - Constantine, G. M. AU - Studenski, S. A. PY - 2009 DA - 2009// TI - Age-associated leukoaraiosis and cortical cholinergic deafferentation JO - Neurology. VL - 72 UR - https://doi.org/10.1212/WNL.0b013e3181a187c6 DO - 10.1212/WNL.0b013e3181a187c6 ID - Bohnen2009 ER - TY - JOUR AU - Robbins, T. W. AU - Arnsten, A. F. PY - 2009 DA - 2009// TI - The neuropsychopharmacology of fronto-executive function: monoaminergic modulation JO - Annu Rev Neurosci VL - 32 UR - https://doi.org/10.1146/annurev.neuro.051508.135535 DO - 10.1146/annurev.neuro.051508.135535 ID - Robbins2009 ER - TY - JOUR AU - Roman, G. C. AU - Kalaria, R. N. PY - 2006 DA - 2006// TI - Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia JO - Neurobiol Aging VL - 27 UR - https://doi.org/10.1016/j.neurobiolaging.2005.10.004 DO - 10.1016/j.neurobiolaging.2005.10.004 ID - Roman2006 ER - TY - JOUR AU - Spivak, B. AU - Vered, Y. AU - Yoran-Hegesh, R. AU - Graff, E. AU - Averbuch, E. AU - Vinokurow, S. PY - 2001 DA - 2001// TI - The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorder JO - Hum Psychopharmacol VL - 16 UR - https://doi.org/10.1002/hup.298 DO - 10.1002/hup.298 ID - Spivak2001 ER - TY - JOUR AU - Padala, P. R. AU - Burke, W. J. AU - Shostrom, V. K. AU - Bhatia, S. C. AU - Wengel, S. P. AU - Potter, J. F. PY - 2010 DA - 2010// TI - Methylphenidate for apathy and functional status in dementia of the Alzheimer type JO - Am J Geriatr Psychiatry VL - 18 UR - https://doi.org/10.1097/JGP.0b013e3181cabcf6 DO - 10.1097/JGP.0b013e3181cabcf6 ID - Padala2010 ER - TY - JOUR AU - Padala, P. R. AU - Padala, K. P. AU - Lensing, S. Y. AU - Ramirez, D. AU - Monga, V. AU - Bopp, M. M. PY - 2018 DA - 2018// TI - Methylphenidate for apathy in community-dwelling older veterans with mild Alzheimer’s disease: a double-blind, randomized, placebo-controlled trial JO - Am J Psychiatry VL - 175 UR - https://doi.org/10.1176/appi.ajp.2017.17030316 DO - 10.1176/appi.ajp.2017.17030316 ID - Padala2018 ER - TY - JOUR AU - Rosenberg, P. B. AU - Lanctot, K. L. AU - Drye, L. T. AU - Herrmann, N. AU - Scherer, R. W. AU - Bachman, D. L. PY - 2013 DA - 2013// TI - Safety and efficacy of methylphenidate for apathy in Alzheimer’s disease: a randomized, placebo-controlled trial JO - J Clin Psychiatry VL - 74 UR - https://doi.org/10.4088/JCP.12m08099 DO - 10.4088/JCP.12m08099 ID - Rosenberg2013 ER - TY - JOUR AU - Lanctot, K. L. AU - Chau, S. A. AU - Herrmann, N. AU - Drye, L. T. AU - Rosenberg, P. B. AU - Scherer, R. W. PY - 2014 DA - 2014// TI - Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial JO - Int Psychogeriatr VL - 26 UR - https://doi.org/10.1017/S1041610213001762 DO - 10.1017/S1041610213001762 ID - Lanctot2014 ER - TY - JOUR AU - Herrmann, N. AU - Rothenburg, L. S. AU - Black, S. E. AU - Ryan, M. AU - Liu, B. A. AU - Busto, U. E. PY - 2008 DA - 2008// TI - Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge JO - J Clin Psychopharmacol VL - 28 UR - https://doi.org/10.1097/JCP.0b013e318172b479 DO - 10.1097/JCP.0b013e318172b479 ID - Herrmann2008 ER - TY - JOUR AU - Galynker, I. AU - Ieronimo, C. AU - Miner, C. AU - Rosenblum, J. AU - Vilkas, N. AU - Rosenthal, R. PY - 1997 DA - 1997// TI - Methylphenidate treatment of negative symptoms in patients with dementia JO - J Neuropsychiatry Clin Neurosci VL - 9 UR - https://doi.org/10.1176/jnp.9.2.231 DO - 10.1176/jnp.9.2.231 ID - Galynker1997 ER - TY - JOUR AU - Albuquerque, E. X. AU - Santos, M. D. AU - Alkondon, M. AU - Pereira, E. F. AU - Maelicke, A. PY - 2001 DA - 2001// TI - Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease JO - Alzheimer Dis Assoc Disord VL - 15 UR - https://doi.org/10.1097/00002093-200108001-00004 DO - 10.1097/00002093-200108001-00004 ID - Albuquerque2001 ER - TY - JOUR AU - Wilcock, G. K. AU - Lilienfeld, S. AU - Gaens, E. PY - 2000 DA - 2000// TI - Efficacy and safety of galantamine in patients with mild to moderate Alzheimer’s disease: multicentre randomised controlled trial. Galantamine International-1 Study Group JO - BMJ. VL - 321 UR - https://doi.org/10.1136/bmj.321.7274.1445 DO - 10.1136/bmj.321.7274.1445 ID - Wilcock2000 ER - TY - JOUR AU - Birks, J. AU - Craig, D. PY - 2006 DA - 2006// TI - Galantamine for vascular cognitive impairment JO - Cochrane Database Syst Rev VL - 4 ID - Birks2006 ER - TY - JOUR AU - Erkinjuntti, T. AU - Kurz, A. AU - Gauthier, S. AU - Bullock, R. AU - Lilienfeld, S. AU - Damaraju, C. V. PY - 2002 DA - 2002// TI - Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial JO - Lancet. VL - 359 UR - https://doi.org/10.1016/S0140-6736(02)08267-3 DO - 10.1016/S0140-6736(02)08267-3 ID - Erkinjuntti2002 ER - TY - JOUR AU - Auchus, A. P. AU - Brashear, H. R. AU - Salloway, S. AU - Korczyn, A. D. AU - Deyn, P. P. AU - Gassmann-Mayer, C. PY - 2007 DA - 2007// TI - Galantamine treatment of vascular dementia: a randomized trial JO - Neurology. VL - 69 UR - https://doi.org/10.1212/01.wnl.0000266625.31615.f6 DO - 10.1212/01.wnl.0000266625.31615.f6 ID - Auchus2007 ER - TY - JOUR AU - Gorelick, P. B. AU - Scuteri, A. AU - Black, S. E. AU - Decarli, C. AU - Greenberg, S. M. AU - Iadecola, C. PY - 2011 DA - 2011// TI - Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association JO - Stroke. VL - 42 UR - https://doi.org/10.1161/STR.0b013e3182299496 DO - 10.1161/STR.0b013e3182299496 ID - Gorelick2011 ER - TY - JOUR AU - Leijenaar, J. F. AU - Groeneveld, G. J. AU - Flier, W. M. AU - Scheltens, P. AU - Klaassen, E. S. AU - Weinstein, H. C. PY - 2018 DA - 2018// TI - Symptomatic treatment of vascular cognitive impairment (STREAM-VCI): protocol for a cross-over trial JO - JMIR Res Protoc VL - 7 UR - https://doi.org/10.2196/resprot.9192 DO - 10.2196/resprot.9192 ID - Leijenaar2018 ER - TY - JOUR AU - Groeneveld, G. J. AU - Hay, J. L. AU - Gerven, J. M. PY - 2016 DA - 2016// TI - Measuring blood-brain barrier penetration using the NeuroCart, a CNS test battery JO - Drug Discov Today Technol VL - 20 UR - https://doi.org/10.1016/j.ddtec.2016.07.004 DO - 10.1016/j.ddtec.2016.07.004 ID - Groeneveld2016 ER - TY - JOUR AU - Ilieva, I. P. AU - Hook, C. J. AU - Farah, M. J. PY - 2015 DA - 2015// TI - Prescription stimulants’ effects on healthy inhibitory control, working memory, and episodic memory: a meta-analysis JO - J Cogn Neurosci VL - 27 UR - https://doi.org/10.1162/jocn_a_00776 DO - 10.1162/jocn_a_00776 ID - Ilieva2015 ER - TY - JOUR AU - Klinge, C. AU - Shuttleworth, C. AU - Muglia, P. AU - Nobre, A. C. AU - Harmer, C. J. AU - Murphy, S. E. PY - 2018 DA - 2018// TI - Methylphenidate enhances implicit learning in healthy adults JO - J Psychopharmacol VL - 32 UR - https://doi.org/10.1177/0269881117731472 DO - 10.1177/0269881117731472 ID - Klinge2018 ER - TY - JOUR AU - Agay, N. AU - Yechiam, E. AU - Carmel, Z. AU - Levkovitz, Y. PY - 2014 DA - 2014// TI - Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis JO - J Clin Psychopharmacol VL - 34 UR - https://doi.org/10.1097/JCP.0000000000000076 DO - 10.1097/JCP.0000000000000076 ID - Agay2014 ER - TY - JOUR AU - Campo, N. AU - Fryer, T. D. AU - Hong, Y. T. AU - Smith, R. AU - Brichard, L. AU - Acosta-Cabronero, J. PY - 2013 DA - 2013// TI - A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment JO - Brain. VL - 136 UR - https://doi.org/10.1093/brain/awt263 DO - 10.1093/brain/awt263 ID - Campo2013 ER - TY - JOUR AU - Ahmed, M. e. h. n. a. z. AU - Malik, M. a. r. l. e. n. e. AU - Teselink, J. o. h. a. n. n. e. s. AU - Lanctôt, K. r. i. s. t. a. L. AU - Herrmann, N. a. t. h. a. n. PY - 2019 DA - 2019// TI - Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia JO - Drugs & Aging VL - 36 UR - https://doi.org/10.1007/s40266-019-00668-7 DO - 10.1007/s40266-019-00668-7 ID - Ahmed2019 ER - TY - JOUR AU - Lohner, V. AU - Brookes, R. L. AU - Hollocks, M. J. AU - Morris, R. G. AU - Markus, H. S. PY - 2017 DA - 2017// TI - Apathy, but not depression, is associated with executive dysfunction in cerebral small vessel disease JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0176943 DO - 10.1371/journal.pone.0176943 ID - Lohner2017 ER - TY - JOUR AU - Marin, R. S. AU - Biedrzycki, R. C. AU - Firinciogullari, S. PY - 1991 DA - 1991// TI - Reliability and validity of the Apathy Evaluation Scale JO - Psychiatry Res VL - 38 UR - https://doi.org/10.1016/0165-1781(91)90040-V DO - 10.1016/0165-1781(91)90040-V ID - Marin1991 ER - TY - JOUR AU - Cummings, J. L. AU - Mega, M. AU - Gray, K. AU - Rosenberg-Thompson, S. AU - Carusi, D. A. AU - Gornbein, J. PY - 1994 DA - 1994// TI - The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia JO - Neurology. VL - 44 UR - https://doi.org/10.1212/WNL.44.12.2308 DO - 10.1212/WNL.44.12.2308 ID - Cummings1994 ER - TY - JOUR AU - Yesavage, J. A. AU - Brink, T. L. AU - Rose, T. L. AU - Lum, O. AU - Huang, V. AU - Adey, M. PY - 1982 DA - 1982// TI - Development and validation of a geriatric depression screening scale: a preliminary report JO - J Psychiatr Res VL - 17 UR - https://doi.org/10.1016/0022-3956(82)90033-4 DO - 10.1016/0022-3956(82)90033-4 ID - Yesavage1982 ER - TY - JOUR AU - Furth, K. E. AU - Mastwal, S. AU - Wang, K. H. AU - Buonanno, A. AU - Vullhorst, D. PY - 2013 DA - 2013// TI - Dopamine, cognitive function, and gamma oscillations: role of D4 receptors JO - Front Cell Neurosci VL - 7 UR - https://doi.org/10.3389/fncel.2013.00102 DO - 10.3389/fncel.2013.00102 ID - Furth2013 ER - TY - JOUR AU - Nottage, J. F. AU - Horder, J. PY - 2015 DA - 2015// TI - State-of-the-art analysis of high-frequency (gamma range) electroencephalography in humans JO - Neuropsychobiology. VL - 72 UR - https://doi.org/10.1159/000382023 DO - 10.1159/000382023 ID - Nottage2015 ER - TY - JOUR AU - Dolder, C. R. AU - Davis, L. N. AU - McKinsey, J. PY - 2010 DA - 2010// TI - Use of psychostimulants in patients with dementia JO - Ann Pharmacother VL - 44 UR - https://doi.org/10.1345/aph.1P341 DO - 10.1345/aph.1P341 ID - Dolder2010 ER - TY - JOUR AU - Habel, L. A. AU - Cooper, W. O. AU - Sox, C. M. AU - Chan, K. A. AU - Fireman, B. H. AU - Arbogast, P. G. PY - 2011 DA - 2011// TI - ADHD medications and risk of serious cardiovascular events in young and middle-aged adults JO - JAMA. VL - 306 UR - https://doi.org/10.1001/jama.2011.1830 DO - 10.1001/jama.2011.1830 ID - Habel2011 ER - TY - JOUR AU - Galvin, J. E. AU - Cornblatt, B. AU - Newhouse, P. AU - Ancoli-Israel, S. AU - Wesnes, K. AU - Williamson, D. PY - 2008 DA - 2008// TI - Effects of galantamine on measures of attention - results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil JO - Alz Dis Assoc Dis VL - 22 UR - https://doi.org/10.1097/WAD.0b013e3181630b81 DO - 10.1097/WAD.0b013e3181630b81 ID - Galvin2008 ER - TY - JOUR AU - Adler, G. AU - Brassen, S. AU - Chwalek, K. AU - Dieter, B. AU - Teufel, M. PY - 2004 DA - 2004// TI - Prediction of treatment response to rivastigmine in Alzheimer’s dementia JO - J Neurol Neurosurg Psychiatry VL - 75 ID - Adler2004 ER - TY - JOUR AU - Straaten, E. C. AU - Scheltens, P. AU - Gouw, A. A. AU - Stam, C. J. PY - 2014 DA - 2014// TI - Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics JO - Alzheimers Res Ther VL - 6 UR - https://doi.org/10.1186/s13195-014-0086-x DO - 10.1186/s13195-014-0086-x ID - Straaten2014 ER - TY - STD TI - Baakman AC, 't Hart E., Kay D G, Stevens J, Klaassen E S, Maelicke A, Groeneveld G J. First in human study with a prodrug of galantamine. Alzheimer’s Dement 2016;2(1):13–22. ID - ref37 ER - TY - JOUR AU - Tariot, P. N. AU - Solomon, P. R. AU - Morris, J. C. AU - Kershaw, P. AU - Lilienfeld, S. AU - Ding, C. PY - 2000 DA - 2000// TI - A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group JO - Neurology. VL - 54 UR - https://doi.org/10.1212/WNL.54.12.2269 DO - 10.1212/WNL.54.12.2269 ID - Tariot2000 ER - TY - JOUR AU - Raskind, M. A. AU - Peskind, E. R. AU - Wessel, T. AU - Yuan, W. PY - 2000 DA - 2000// TI - Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group JO - Neurology. VL - 54 UR - https://doi.org/10.1212/WNL.54.12.2261 DO - 10.1212/WNL.54.12.2261 ID - Raskind2000 ER -